BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17908404)

  • 1. Maternal serum hormone concentrations for prediction of adverse outcome in threatened miscarriage.
    Johns J; Muttukrishna S; Lygnos M; Groome N; Jauniaux E
    Reprod Biomed Online; 2007 Oct; 15(4):413-21. PubMed ID: 17908404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages.
    Muttukrishna S; Jauniaux E; Greenwold N; McGarrigle H; Jivraj S; Carter S; Elgaddal S; Groome N; Regan L
    Hum Reprod; 2002 Dec; 17(12):3072-8. PubMed ID: 12456605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis.
    Pillai RN; Konje JC; Tincello DG; Potdar N
    Hum Reprod Update; 2016; 22(2):228-39. PubMed ID: 26663220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage from 5 to 13 weeks gestation: a prospective cohort study.
    Ku CW; Allen JC; Lek SM; Chia ML; Tan NS; Tan TC
    BMC Pregnancy Childbirth; 2018 Sep; 18(1):360. PubMed ID: 30185145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First trimester levels of inhibins and activin A in normal and failing pregnancies.
    Wallace EM; Marjono B; Tyzack K; Tong S
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):484-90. PubMed ID: 15049964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of determinations of human chorionic gonatrophin, human placental lactogen, progesterone and oestriol in women with threatened abortion (author's transl)].
    Gerhard I; Runnebaum B
    Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):785-99. PubMed ID: 700341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy.
    Muttukrishna S; Child TJ; Groome NP; Ledger WL
    Hum Reprod; 1997 May; 12(5):1089-93. PubMed ID: 9194671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
    Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
    BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage.
    Prakash A; Laird S; Tuckerman E; Li TC; Ledger WL
    Fertil Steril; 2005 Jun; 83(6):1758-63. PubMed ID: 15950648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vivo concentrations of inhibins, activin A and follistatin in human early pregnancy.
    Muttukrishna S; Jauniaux E; McGarrigle H; Groome N; Rodeck CH
    Reprod Biomed Online; 2004 Jun; 8(6):712-9. PubMed ID: 15169590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of placental protein 13, β-human chorionic gonadotropin and progesterone in the prediction of miscarriages in threatened miscarriage patients.
    Yalçin I; Taşkin S; Pabuçcu EG; Söylemez F
    J Obstet Gynaecol; 2015 Apr; 35(3):283-6. PubMed ID: 25153203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
    Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive to immunoreactive ratio of circulating human chorionic gonadotropin as possible evaluation for the prognosis of threatened abortion.
    Camejo MI; Proverbio F; Febres F; Casart YC
    Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):181-4. PubMed ID: 12860338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can we better predict the risk of spontaneous miscarriage among women experiencing threatened miscarriage?
    Ku CW; Allen JC; Malhotra R; Chong HC; Tan NS; Østbye T; Lek SM; Lie D; Tan TC
    Gynecol Endocrinol; 2015; 31(8):647-51. PubMed ID: 26036717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of human chorionic gonadotrophin and immunoreactive inhibin in early pregnancy and recurrent miscarriage: a longitudinal study.
    France JT; Keelan J; Song L; Liddell H; Zanderigo A; Knox B
    Aust N Z J Obstet Gynaecol; 1996 Aug; 36(3):325-30. PubMed ID: 8883762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunoactive inhibin levels in early pregnancy after in vitro fertilization and embryo transfer.
    Yohkaichiya T; Polson DW; Hughes EG; MacLachlan V; Robertson DM; Healy DL; de Kretser DM
    Fertil Steril; 1993 May; 59(5):1081-9. PubMed ID: 8486178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational hormone trajectories and early pregnancy failure: a reassessment.
    Whittaker PG; Schreiber CA; Sammel MD
    Reprod Biol Endocrinol; 2018 Oct; 16(1):95. PubMed ID: 30309358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
    Yu J; Shixia CZ; Wu Y; Duan T
    Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage.
    Luisi S; Florio P; D'Antona D; Severi FM; Sanseverino F; Danero S; Petraglia F
    Eur J Endocrinol; 2003 Feb; 148(2):233-6. PubMed ID: 12590643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.
    Qureshi NS; Edi-Osagie EC; Ogbo V; Ray S; Hopkins RE
    BJOG; 2005 Nov; 112(11):1536-41. PubMed ID: 16225575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.